Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Unda

Showing results (61-70 of 79) with videos related to

Pageof 8
Sort By:
Actas Urologicas Espanolas|November 8, 2016
Castrate resistant prostate cancer. Consensus recommendations of the Spanish Association of UrologyA Loizaga-Iriarte, A Rodriguez-Antolin, B Miñana, et al.
Actas Urologicas Espanolas|November 3, 2022
Identifying prognostic parameters related to surgical technique in patients treated by robotic radical prostatectomyA Loizaga Iriarte, I Lacasa Viscasillas, S Rey Gonzalez, et al.
Actas Urologicas Espanolas|February 29, 2016
Retrospective study of various conservative treatment options with bacille Calmette-Guérin in bladder urothelial carcinoma T1G3: Maintenance therapyJ Palou-Redorta, E Solsona, J Angulo, et al.
Actas Urologicas Espanolas|July 17, 2017
Radium-223 in the therapeutic sequence of metastatic castration-resistant prostate cancerM Unda-Urzaiz, R Sousa-Campo, A Rodríguez-Antolín, et al.
Actas Urologicas Espanolas|November 1, 2024
Optimizing triple therapy in patients with metastatic hormone-sensitive prostate cancerA Borque-Fernando, D A Pérez-Fentes, M Rodrigo-Aliaga, et al.
Actas Urologicas Espanolas|June 10, 2023
Abiraterone in low-volume metastatic hormone-sensitive prostate cancer. Authors' replyA Borque-Fernando, M A Calleja-Hernández, J M Cózar-Olmo, et al.
Actas Urologicas Espanolas|January 31, 2023
A multidisciplinary consensus statement on the optimal pharmacological treatment for metastatic hormone-sensitive prostate cancerA Borque-Fernando, M A Calleja-Hernández, J M Cózar-Olmo, et al.
Actas Urologicas Espanolas|January 3, 2016
Treatment trends for clinically localised prostate cancer. National population analysis: GESCAP groupB Miñana, A Rodríguez-Antolín, F Gómez-Veiga, et al.
Actas Urologicas Espanolas|May 18, 2019
Safety of nivolumab in metastatic renal cell carcinoma patients: A real-life experience in a Spanish urology settingJ Amores Bermúdez, I Osman García, M Unda Urzáiz, et al.
Actas Urologicas Espanolas|September 28, 2024
Consensus document on the implications of standardization of BCG supply in the management of patients with non-muscle-invasive bladder cancerÓ Rodríguez Faba, J M Fernández Gómez, F Guerrero-Ramos, et al.
Pageof 8

Showing results (61-70 of 79) with videos related to

Sort By:
Pageof 8
Actas Urologicas Espanolas|November 8, 2016
Castrate resistant prostate cancer. Consensus recommendations of the Spanish Association of UrologyA Loizaga-Iriarte, A Rodriguez-Antolin, B Miñana, et al.
Actas Urologicas Espanolas|November 3, 2022
Identifying prognostic parameters related to surgical technique in patients treated by robotic radical prostatectomyA Loizaga Iriarte, I Lacasa Viscasillas, S Rey Gonzalez, et al.
Actas Urologicas Espanolas|February 29, 2016
Retrospective study of various conservative treatment options with bacille Calmette-Guérin in bladder urothelial carcinoma T1G3: Maintenance therapyJ Palou-Redorta, E Solsona, J Angulo, et al.
Actas Urologicas Espanolas|July 17, 2017
Radium-223 in the therapeutic sequence of metastatic castration-resistant prostate cancerM Unda-Urzaiz, R Sousa-Campo, A Rodríguez-Antolín, et al.
Actas Urologicas Espanolas|November 1, 2024
Optimizing triple therapy in patients with metastatic hormone-sensitive prostate cancerA Borque-Fernando, D A Pérez-Fentes, M Rodrigo-Aliaga, et al.
Actas Urologicas Espanolas|June 10, 2023
Abiraterone in low-volume metastatic hormone-sensitive prostate cancer. Authors' replyA Borque-Fernando, M A Calleja-Hernández, J M Cózar-Olmo, et al.
Actas Urologicas Espanolas|January 31, 2023
A multidisciplinary consensus statement on the optimal pharmacological treatment for metastatic hormone-sensitive prostate cancerA Borque-Fernando, M A Calleja-Hernández, J M Cózar-Olmo, et al.
Actas Urologicas Espanolas|January 3, 2016
Treatment trends for clinically localised prostate cancer. National population analysis: GESCAP groupB Miñana, A Rodríguez-Antolín, F Gómez-Veiga, et al.
Actas Urologicas Espanolas|May 18, 2019
Safety of nivolumab in metastatic renal cell carcinoma patients: A real-life experience in a Spanish urology settingJ Amores Bermúdez, I Osman García, M Unda Urzáiz, et al.
Actas Urologicas Espanolas|September 28, 2024
Consensus document on the implications of standardization of BCG supply in the management of patients with non-muscle-invasive bladder cancerÓ Rodríguez Faba, J M Fernández Gómez, F Guerrero-Ramos, et al.
Pageof 8